295 related articles for article (PubMed ID: 10686642)
1. [Familial hypercholesterolemia].
Turpin G; Bruckert E
Ann Med Interne (Paris); 1999 Dec; 150(8):605-14. PubMed ID: 10686642
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of coronary heart disease in familial hypercholesterolemia].
Miserez AR; Keller U
Ther Umsch; 1994 Oct; 51(10):671-6. PubMed ID: 7839323
[TBL] [Abstract][Full Text] [Related]
4. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein metabolism in familial hypercholesterolemia.
Shepherd J; Packard CJ
Arteriosclerosis; 1989; 9(1 Suppl):I39-42. PubMed ID: 2912431
[TBL] [Abstract][Full Text] [Related]
6. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation.
Schmidt HH; Tietge UJ; Buettner J; Barg-Hock H; Offner G; Schweitzer S; Dedoussis GV; Rodeck B; Kallfelz HC; Schlitt HJ; Oldhafer K; Klempnauer J
Clin Transplant; 2008; 22(2):180-4. PubMed ID: 18339137
[TBL] [Abstract][Full Text] [Related]
8. [LDL receptors].
Ducobu J
Rev Med Brux; 1990 Dec; 11(10):481-92. PubMed ID: 2293288
[TBL] [Abstract][Full Text] [Related]
9. Familial hypercholesterolemia: dissection of a receptor disease.
Schneider WJ
Z Kardiol; 1990; 79 Suppl 3():3-7. PubMed ID: 2099041
[TBL] [Abstract][Full Text] [Related]
10. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
11. [LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment].
Napoli C; Postiglione A; Scarpato N; Corso G; Ambrosio G; Condorelli M; Mancini M; Chiariello M
Cardiologia; 1996 May; 41(5):435-9. PubMed ID: 8767632
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of blood cholesterol, mechanism of hypercholesterolemia].
Luc G; Douste-Blazy P; Fruchart JC
Rev Prat; 1989 Apr; 39(12):1019-22. PubMed ID: 2740766
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
Sachais BS; Katz J; Ross J; Rader DJ
J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
[TBL] [Abstract][Full Text] [Related]
15. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
16. Watanabe heritable hyperlipidemic rabbit. Animal model for familial hypercholesterolemia.
Havel RJ; Yamada N; Shames DM
Arteriosclerosis; 1989; 9(1 Suppl):I33-8. PubMed ID: 2643428
[TBL] [Abstract][Full Text] [Related]
17. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
18. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.
Bilheimer DW; East C; Grundy SM; Nora JJ
Am J Med Genet; 1985 Nov; 22(3):593-8. PubMed ID: 4061492
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse.
Tomita N; Morishita R; Koike H; Hashizume M; Notake M; Fujitani B; Kaneda Y; Horiuchi M; Ogihara T
Int J Mol Med; 2002 Aug; 10(2):137-43. PubMed ID: 12119548
[TBL] [Abstract][Full Text] [Related]
20. Aggressive lipid lowering treatment in coronary atherosclerosis.
Stalenhoef AF; Kroon AA; Aengevaeren WR
Cardiologia; 1997 Sep; 42(9):935-40. PubMed ID: 9369038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
